Disrupted RAS-RAF-MEK-MAPK signaling through activating Ras mutation has been reported as a major modulator of ELK1 in PaCa [66,268,269,270,271,272]. This evidence concerns the gene ELK1 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.